DUSA Pharmaceuticals
For Physicians  |  For Investors  |  For Pharmacists  |  Contact Us
HomeProductsAbout DUSANews/Events
2007 Press Releases
  • November 9, 2007 Quarterly Conference Call
  • November 9, 2007
  • November 1, 2007
  • October 30, 2007
  • October 30, 2007
  • September 5, 2007 - Presentation
  • October 29, 2007
  • August 14, 2007
  • October 29, 2007
  • October 8, 2007
  • October 3, 2007
  • October 1, 2007
  • August 21, 2007 - Presentation
  • August 28, 2007
  • August 15, 2007
  • August 7, 2007 Quarterly Conference Call
  • August 7, 2007
  • August 2, 2007
  • May 30, 2007 - Presentation
  • June 25, 2007
  • June 14, 2007
  • May 25, 2007
  • May 17, 2007
  • May 4, 2007 Quarterly Conference Call
  • May 4, 2007
  • March 16, 2007
  • May 1, 2007
  • March 13, 2007
  • March 8, 2007
  • February 7, 2007
  • January 23, 2007
  • January 8, 2007
Home » News/Events » Press Releases » 2007 Press Releases

May 30, 2007 - Presentation
DUSA Presentation at FBR Conference

May 25, 2007
DUSA Pharmaceutials to Present at the Friedman, Billings, Ramsey & Co., Inc. 2007 Growth Conference

May 17, 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan® PDT to Treat Esophageal Dysplasia

May 4, 2007 Quarterly Conference Call
May 4, 2007 Conference Call - First Quarter 2007 Corporate Highlights and Financial Results

May 4, 2007
DUSA Pharmaceuticals Reports First Quarter 2007 Corporate Highlights and Financial Results

May 1, 2007
DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call

March 16, 2007
DUSA Pharmaceuticals Reports Fourth-Quarter and Year-End 2006 Financial Results

March 13, 2007
DUSA Pharmaceuticals, Inc. to Host Fourth Quarter and Full Year 2006 Financial Results and Corporate Highlights Conference Call

March 8, 2007
DUSA Pharmacueticals Reports Court Ruling Lifting Injunction Against River's Edge Sales of Generic Nicomide®

February 7, 2007
A Global Review at the American Academy of Dermatology Annual Meeting Champions Photodynamic Therapy as a First Line Treatment for Patients at Risk for Skin Cancer

< Previous 1234 Next >

 

Customer Service | Reimbursement/Insurance Coverage
Careers | Legal Notice/Privacy Policy
© 2010, DUSA Pharmaceuticals, Inc.
All Rights Reserved.